About the Authors
- Thomas Land
-
* E-mail: Thomas.Land@state.ma.us
Affiliation Massachusetts Tobacco Cessation and Prevention Program, Boston, Massachusetts, United States of America
- Nancy A. Rigotti
-
Affiliations Tobacco Research and Treatment Center, General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, Mongan Institute for Health Policy, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
- Douglas E. Levy
-
Affiliations Tobacco Research and Treatment Center, General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, Mongan Institute for Health Policy, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
- Mark Paskowsky
-
Affiliation Massachusetts Tobacco Cessation and Prevention Program, Boston, Massachusetts, United States of America
- Donna Warner
-
Affiliation Massachusetts Tobacco Cessation and Prevention Program, Boston, Massachusetts, United States of America
- Jo-Ann Kwass
-
Affiliation Massachusetts Tobacco Cessation and Prevention Program, Boston, Massachusetts, United States of America
- LeAnn Wetherell
-
Affiliation Office of Medicaid Commonwealth of Massachusetts, Boston, Massachusetts, United States of America
- Lois Keithly
-
Affiliation Massachusetts Tobacco Cessation and Prevention Program, Boston, Massachusetts, United States of America
Competing Interests
In the past 5 years, NAR's institution has received research grant funding from Pfizer and Nabi Biopharmaceuticals for the study of investigational and/or marketed smoking cessation products. She has consulted for Pfizer and Free & Clear. She does not accept payment for consultation and has not for the past two years.
Author Contributions
ICMJE criteria for authorship read and met: TL NAR DEL MP DW JAK LW LK. Agree with the manuscript's results and conclusions: TL NAR DEL MP DW JAK LW LK. Designed the experiments/the study: TL DEL DW JAK LK. Analyzed the data: TL DEL MP LW. Collected data/did experiments for the study: TL MP LW. Wrote the first draft of the paper: TL. Contributed to the writing of the paper: NAR DEL DW JAK LW LK. Advised on design and analysis plan: NAR. Oversaw study design, contributed to implementation, and oversaw evaluation of MassHealth benefit: LK.